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AsmanyDNA-damagingconditionsrepresstranscription,posttranscriptionalprocessescriticallyinﬂuencegeneexpressionduring
the genotoxic stress response. The RNA-binding protein HuR robustly inﬂuences gene expression following DNA damage. HuR
function is controlled in two principal ways: (1) by mobilizing HuR from the nucleus to the cytoplasm, where it modulates
the stability and translation of target mRNAs and (2) by altering its association with target mRNAs. Here, we review evidence
that two main eﬀectors of ataxia-telangiectasia-mutated/ATM- and Rad3-related (ATM/ATR), the checkpoint kinases Chk1 and
Chk2, jointly inﬂuence HuR function. Chk1 aﬀects HuR localization by phosphorylating (hence inactivating) Cdk1, a kinase
that phosphorylates HuR and thereby blocks HuR’s cytoplasmic export. Chk2 modulates HuR binding to target mRNAs by
phosphorylating HuR’s RNA-recognition motifs (RRM1 and RRM2). We discuss how HuR phosphorylation by kinases including
Chk1/Cdk1 and Chk2 impacts upon gene expression patterns, cell proliferation, and survival following genotoxic injury.
1.Introduction
Damage to the cellular DNA can transiently inhibit the
a c t i v i t yo fR N Ap o l y m e r a s eI Ia tat i m ew h e nD N Ad a m a g e
response (DDR) proteins and DNA repair proteins are
critically needed [1]. As transcription is reduced, there
is increased need to regulate the production of proteins
from the pre-existing pool of mRNAs. Two main posttran-
scriptional mechanisms control protein expression follow-
ing genotoxic damage: mRNA turnover and translational
regulation [2, 3]. These two sets of events are potently
inﬂuenced by RNA-binding proteins (RBPs) and noncoding
RNAs (primarily microRNAs), which interact with mRNAs
and modulate their half-lives and translation rates [4–6].
During the DDR, several RBPs showing altered levels or
subcellular localization have been implicated in controlling
gene expression. For example, many RBPs that control
RNA metabolism showed altered expression in response to
ionizing radiation (IR) and ultraviolet radiation (UV) [7];
in another study, several members of the heterogeneous
ribonuclear protein (hnRNP) family were found to partici-
pate in the response to IR [8]. Speciﬁc RBPs have also been
shown to participate in diﬀerent types of DDR; for example,
the RBPs AU-binding factor 1 (AUF1) and T cell-restricted
intracellular antigen-related protein (TIAR) controlled the
expression of the growth arrest- and DNA damage-inducible
(gadd)45aproteininresponsetoalkylatingDNAdamage[9],
the RBPs nucleolin and nucleophosmin participated in the
cellular responses to IR and UV [10], and the RBP Sam68
modulated alternative splicing following DNA damage [11].
Oneofthe bestcharacterizedRBPsthatcontrolexpressionof
DDR genes, HuR, is the subject of this review.
2. Stress-Response ProteinHuR
HuR is the ubiquitous member of the embryonic lethal
abnormal vision (ELAV)/Hu family of RBPs, which also
contains the primarily neuronal members HuB, HuC, and
HuD [12]. Although HuR is predominantly nuclear, its
translocation to the cytoplasm is linked to its ability to
stabilize target mRNAs and/or modulate their translation
[13, 14]. The 326-aa long HuR binds target mRNAs through
its three RNA recognition motifs (RRMs); located between
RRM2 and RRM3 is a hinge region that encompasses
a nucleocytoplasmic shuttling sequence (HNS, spanning2 Journal of Nucleic Acids
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Figure 1: Sites of HuR phosphorylation by DNA damage-inducible kinases. Schematic of HuR depicting the RNA recognition motifs
(RRMs, dark blue), the hinge region (brown) with the HuR nucleocytoplasmic shuttling sequence (HNS), the sites of phosphorylation
(under “Phosphorylated Amino Acids”), and the DNA Damage-Regulated Kinases responsible, including an unknown kinase predicted to
phosphorylate S242. The consequences of HuR phosphorylation at the diﬀerent sites are indicated under “Impact on HuR Function”. More
details in the text.
residues 205–237 [15]) (Figure 1). The nuclear export of
HuR is mediated by its association with transportin 1 (Trn1)
and Trn2 [16] and with nuclear ligands pp32 and APRIL,
which contain nuclear export signals that are recognized by
the export receptor CRM1 [17, 18].
HuR target mRNAs encode many proteins implicated
in the cellular response to DNA damage, including tumor
suppressors (p53, pVHL), cyclins (A, B1, and D1), proto-
oncogenes (c-fos, c-myc), growth factors (VEGF), cytokines
(TGF-β,T N F - α), cyclin-dependent kinase (cdk) inhibitors
(p21, p27), antiapoptotic factors [prothymosin α (ProTα),
Bcl-2, and Mcl-1], and signaling molecules like the mitogen-
activated protein (MAP) kinase phosphatase MKP-1 [19–
30]( Table 1); most of these transcripts contain one or
several copies of a U-rich RNA signature motif [31]. Given
the functions of the proteins encoded by HuR-regulated
mRNAs, HuR has been implicated in processes such as
carcinogenesis, proliferation, immune function, diﬀerentia-
tion, and responsiveness to oxidative and genotoxic damage
[14, 26, 32–38].
With a few exceptions [38, 44], acute changes in HuR
function do not involve changes in protein abundance but
rely instead on two regulatory steps: (1) the subcellular
localization of HuR and (2) the interaction of HuR with
target mRNAs. In response to DNA-damaging stresses, the
past few years have uncovered a signaling pathway that
jointly aﬀects both of these processes, HuR’s subcellular
distribution and its interaction with target transcripts. DNA
damage is recognized by sensor proteins, such as the Rad9-
Rad1-Hus1 complex (also termed “9-1-1 complex”) that
recognizes certain types of DNA damage and is mediated
by proteins such as those that comprise the Mre11-Rad50-
Nbs1 complex (MRN), which recruits the transducer protein
DNA damage-activated ataxia telangiectasia mutated (ATM)
to sites of DNA damage [45]. The transducer proteins
include the kinases ATM and ATM- and Rad3-related
(ATR); ATM/ATR phosphorylates and thereby activates the
checkpoint kinases Chk1 and Chk2, which control HuR
cytoplasmic abundance and RNA binding, respectively. ATM
is primarily activated by double-strand breaks in DNA,
such as those caused by IR [46] while ATR is activated in
response to other damaging agents, including UV, alkylating
agents, and chemical inhibitors of DNA replication [47, 48],
but there is extensive evidence that both kinases work in
tandem [49]. As these kinases are essential for genomic
integrity, deﬁciencies in ATM/ATR and other components of
DNA damage checkpoints cause debilitating diseases such as
ataxiatelangiectasia,Fanconi’sanemia,andSeckelsyndrome,Journal of Nucleic Acids 3
Table 1: HuR target mRNAs showing altered expression after DNA damage. Partial list of HuR target mRNAs encoding proteins that change
following DNA damage (ﬁrst column), the region of interaction with HuR (second column), and the genotoxic damage that was shown to
aﬀect HuR regulation of the mRNA (third column); “n.r.”: no reported. The HuR kinases linked to the regulation of the mRNAs in the ﬁrst
column are indicated (fourth column).
Target mRNA after
DNA damage Binding region DNA damage conditions aﬀecting
regulation by HuR HuR Kinase References
mRNA stabilization
c-fos 3 UTR n.r. n.r. [−]
p21 3 UTR UVC, arsenite, IR Chk2, p38 [27, 39]
cyclin A2 3 UTR H2O2 Chk2, Cdk1 [27, 29]
cyclin B1 3 UTR H2O2 n.r. [40]
cyclin D1 3 UTR UVC Chk2 [27]
iNOS 3 UTR n.r. n.r. [−]
VEGF 3 UTR n.r. n.r. [−]
SIRT1 3 UTR H2O2 Chk2 [27]
TNF-α 3 UTR n.r. n.r. [−]
bcl-2 3 UTR n.r. Cdk1 [28]
mcl-1 3 UTR n.r. Cdk1 [28]
COX-2 3 UTR n.r. PKC, p38 [41, 42]
uPA 3 UTR n.r. n.r. [−]
uPAR 3 UTR n.r. n.r. [−]
IL-3 3 UTR n.r. n.r. [−]
MKP-1 3 UTR H2O2 Cdk1 [43]
↑ Translation
p53 3 UTR UVC n.r. [−]
ProTα 3 UTR UVC Chk2, Cdk1 [29]
cytochrome c 3 UTR n.r. Chk2 [27]
MKP-1 3 UTR H2O2 Cdk1 [29]
HIF-1α 3 UTR n.r. Cdk1 [29]
↓ Translation
p27 5 UTR n.r. n.r. [−]
IGF-IR 5 UTR n.r. n.r. [−]
Wnt5a 3 UTR n.r. n.r. [−]
HuR 3 UTR n.r. n.r. [−]
c-Myc 3 UTR n.r. n.r. [−]
thereby contributing to premature aging and carcinogenesis
[50, 51]. Given that HuR target transcripts encode proteins
implicatedintheDDR,HuRcontrolbyATM/ATRisrisingas
a major gene regulatory paradigm in the pathophysiology of
DNA damage (Figure 2). Consequently, even in the presence
of normal HuR levels in the cell, HuR’s ability to regulate
DDR gene expression posttranscriptionally is impaired in
cells with aberrant ATM/ATR signaling.
3. Regulation of HuR by
ATM/ATR → Chk1   Cdk1
During DDR such as that resulting from exposure to UV,
oxidants, or IR, Chk1 is phosphorylated by ATM/ATR at
serine (S)317 and S345 [52]. Chk1 plays a pivotal role in
the regulation of the cell division cycle by phosphorylating
proteins such as the cyclin-dependent kinase 1 (Cdk1, also
named Cdc2). ATM/ATR → Chk1 signaling leads to the
inactivation of a dual-speciﬁcity phosphatase, Cdc25, which
consists of three members (A, B, and C). Chk1 phosphory-
lates Cdc25A at S76, a modiﬁcation that triggers the degra-
dation of Cdc25A via SCFβ-TRCP-mediated ubiquitination
[53]. Chk1 also associates with Cdc25B and Cdc25C and
inactivates these phosphatases through phosphorylation at
S309/323andS216,respectively,inturncausingtheirnuclear
exclusion through association with 14-3-3 [54]. Cdk1 is
fully activated in two steps: by phosphorylation at threonine
(T)161 via the kinase Cdk7 and by dephosphorylation of
phosphor- (p-) thyrosine (Y)15 via the phosphatase Cdc25.
Thus, by inhibiting Cdc25, ATM/ATR → Chk1 inactivates
Cdk1. Additionally, Chk1 activates the kinase Wee1, which
is responsible for the inhibitory phosphorylation of Cdk1
at Y15 [55]. As recently reported, during mitosis Cdk1
phosphorylates Chk1 at S286 and S301; the mitotic phos-
phorylation of Chk1 is accompanied by the translocation
of Chk1 to the cytoplasm [56]. Phosphorylation of Chk1
resulting in its removal from chromatin has been shown
to modify cytoplasmic substrates and plays a role at the
centrosome during cell division [57].4 Journal of Nucleic Acids
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Figure 2: Regulation of HuR function by ATM/ATR →
Chk1/Chk2. ATM/ATR regulates HuR function through the acti-
vation of Chk1 and Chk2. Active Chk1 phosphorylates (and hence
inactivates) Cdk1, a kinase that phosphorylates HuR at S202; in
turn, unphosphorylated HuR(S202) can be transported to the
cytoplasm (orange). Active Chk2 phosphorylates HuR at S88, S100,
and T118 (at RRM1 and RRM2); in turn, HuR association with
target mRNAs is altered (purple). Jointly, ATM/ATR → Chk1/Chk2
modulates the amount of HuR in the cytoplasm and its interaction
with target mRNAs (green).
The cellular DDR dynamically regulates the subcellular
presence of HuR. Although predominantly nuclear, exposure
to UV or oxidants triggers the accumulation of HuR in
the cytoplasm [20, 24, 43], where it modulates the stability
and/or translation of numerous target mRNAs, as explained
above. We recently reported that HuR was a direct substrate
for Cdk1, which phosphorylated HuR at S202 [29]. HuR
subcellularlocalizationduringthecelldivisioncyclefollowed
ﬂuctuations in Cdk1 activity [29]. The reduction in Cdk1
activity that followed UV irradiation of HeLa cells resulted
in the loss of HuR phosphorylation at S202, which in
turn promoted the cytoplasmic accumulation of HuR. HuR
translocation following Cdk1 inhibition was linked to the
nuclear interaction of p-HuR(S202) and 14-3-3 [29]. Inhi-
bition or silencing of Cdk1 enhanced the cytoplasmic level
of HuR and increased its interaction with target mRNAs,
including those that encode anti-apoptotic proteins like
Bcl-2, Mcl-1, and prothymosin-α; therefore, lowering Cdk1
also diminished the proapoptotic inﬂuence of etoposide or
staurosporine. Given that DNA damage triggered by many
agents reduces Cdk1 activity and increases the cytoplasmic
presence of HuR, it is likely that the ATM/ATR → Chk1
  Cdk1 pathway is broadly responsible for controlling
the cytoplasmic levels of HuR after diﬀerent types of
DDR.
Other DNA damage-activated pathways also aﬀect HuR
localization through Cdk1. Activation of the MAP kinase
(MAPK) p38 by DNA damage phosphorylates Cdc25B
and thus triggers it for degradation. In this manner,
p38 aﬀects Cdk1 levels through its inﬂuence on Cdc25B
abundance. DNA damage induces the cleavage of PKCδ
and generates a constitutively active catalytic fragment
termed PKCδ-cat. PKCδ-cat can also phosphorylate Cdk1 at
Y15, thereby inactivating Cdk1 and inducing G2/M arrest.
Moreover, PKCδ canphosphorylatedirectlyHuRatS221and
S318 (see below), triggering the cytoplasmic translocation
of HuR [58]. Overall, DNA damage inactivates Cdk1,
which increases cytoplasmic HuR level and thus enhances
mRNA stability and translation of DNA damage response
proteins.
4. Regulation of HuR by ATM/ATR → Chk2
One of the main roles of the ATM/ATR → Chk2 pathway is
to induce cell cycle arrest, allowing cells to repair damaged
DNA [59]; see [60] for a recent review on Chk2 and Chk1.
ActivatedChk2phosphorylatesdownstreameﬀectorssuchas
p53, BRCA1, and Cdc25 and Cdc25A, which are involved in
cellular processes such as apoptosis, DNA repair, and growth
arrest [61].
Exposureofhumandiploidﬁbroblaststogenotoxicdoses
of hydrogen peroxide (H2O2) activated Chk2, which in
turn phosphorylated HuR [27]. HuR phosphorylation by
Chk2 triggered the dissociation of the mRNA encoding
the longevity and stress-response protein SIRT1 from HuR
ribonucleoprotein (RNP) complexes; this dissociation ren-
dered the SIRT1 mRNA unstable and triggered a decrease
in the abundance of SIRT1 mRNA and protein. Three
putative Chk2 phosphorylation sites were identiﬁed: HuR
residues S88, S100, and T118. In human diploid ﬁbroblasts,
mutating S100 to a nonphosphorylatable residue (S100A)
promoted the continued association of SIRT1 mRNA with
HuRafteroxidativedamage,indicatingthatphosphorylation
at residue S100 (located between RRM1 and RRM2) was
critical for dissociation of the mRNA [27]. A more stable
target transcript, the prothymosin α (PTMA) mRNA, also
showedincreasedbindingtoHuR(S100A)comparedtowild-
type HuR following H2O2 treatment. Interestingly, mutation
of T118 (located within RRM2) to a nonphosphorylatable
site (T118A) generally showed reduced binding to all target
mRNAs, suggesting that phosphorylation at T118 enhanced
HuRbindingtotargetmRNAs.Additionalstudiesareneeded
to elucidate if other DNA-damaging agents also act upon
Chk2 to phosphorylate HuR and how these modiﬁcations
aﬀect HuR function following genotoxic stress. Further
work is also necessary to investigate how other HuR target
mRNAs are regulated following HuR phosphorylation by
Chk2.
Unexpectedly, HuR phosphorylation by Chk2 in
response to heat shock helped to prevent its degradation
in this stress paradigm [38]. Following heat shock, the
nonphoshorylatable HuR mutants (S88A, S100A, and
T118A) were more labile while HuR phosphomimic
mutants (S88D, S100D, and T118D) were more resistantJournal of Nucleic Acids 5
to degradation [38]. Although details of this process await
further analysis, Chk2 phosphorylation of HuR appeared to
block HuR proteolysis mediated by ubiquitination at HuR
residue K182 [38]. Whether DNA damage also helps to
increase HuR stability via Chk2-mediated phosphorylation
also warrants careful consideration.
In addition, since Chk2 phosphorylates HuR, and Chk2
mutations inﬂuence Chk2 function, it is important to study
in detail the inﬂuence of Chk2 upon HuR function on target
mRNAs, just as was done for SIRT1 mRNA [27]. Chk2 was
found to be mutated in the Li-Fraumeni cancer syndrome
and in cancer [62, 63]; these mutations modiﬁed Chk2’s
ability to interact with substrates, Chk2 kinase activity, and
Chk2 subcellular localization [59, 64]. How the role of
HuR in gene expression is aﬀected in Chk2 mutant cells
remains unclear and will be an important aim of future
studies.
5.Other HuRKinasesRegulatedby
DNA Damage
Genotoxic damage also activates additional kinases that
control HuR function, including protein kinase C (PKC) and
the MAPK p38. Although less is known about their inﬂuence
on HuR function after DNA damage, they are also expected
to be intimately linked to this response (Figure 1).
5.1. PKC. Protein kinase C (PKC)α was reported to phos-
phorylate HuR at S158 and S221 while PKCδ was phospho-
rylated HuR at S221 and S318 [41, 58, 65, 66]. PKCα and
PKCδ were implicated in the cytoplasmic export of HuR,
its enhanced association with target transcripts (e.g., COX-
2, cyclin D1,a n dcyclin A mRNAs), and their stabilization
[41, 58, 65, 66]. Doller and coworkers primarily examined
the eﬀect of angiotensin II (AngII) in human mesangial cells,
uncovering a complex set of regulatory features. However,
PKC is a bona ﬁde DNA damage response kinase [39, 67].
The inﬂuence of PKC on HuR-modulated gene expression is
a promising area for future study.
5.2. p38. The MAPK p38 plays a key role in the growth arrest
that follows exposure to DNA-damaging agents [68–70]. An
important mediator of this eﬀect is the cdk inhibitor p21,
whose levels increase in response to genotoxins such as IR.
The Nebreda laboratory recently showed that following IR,
p38 phosphorylated HuR at T118, leading to the cytoplasmic
accumulation of HuR, and increased the binding of HuR
to p21 mRNA. p21 mRNA was thus stabilized, leading to
increased expression of p21 protein and to the activation
of the G1/S checkpoint [71]. Inhibiting p38 or using the
non-phosphorylatable mutant HuR(T118A) prevented the
p38-mediated increase in p21 expression after IR, which
abrogated the G1/S arrest. The eﬀect of p38 upon HuR
translocation and binding to target mRNAs appears to
require the p38 downstream substrate MAPKAPK-2 (MK2),
as shown in cells responding to taxanes or oxidants [42,
72], although MK2 does not appear to phosphorylate HuR
directly. While a direct inﬂuence of p38 on HuR after H2O2
has not been studied to date, the mutant HuR(T118A) also
showed reduced binding to p21 mRNA in H2O2-treated
cells[27],suggestingthatH2O2-activatedp38couldsimilarly
change HuR binding to target mRNAs.
5.3. Additional Kinases Aﬀecting HuR Function. The AMP-
activated protein kinase (AMPK) does not phosphorylate
HuR directly, but it phosphorylates and enhances the acety-
lation of importin α1[ 42]; in turn, importin α1 favors the
nuclear import of HuR. Stress conditions that reduce AMPK
a c t i v i t yc a ns u p p r e s st h i si m p o r tp a t h w a y ,t h u sa l l o w i n g
cytoplasmic HuR to accumulate [73]. How DNA damage
aﬀects importin 1α-mediated localization of HuR remains
to be tested directly. Finally, an as-yet unidentiﬁed kinase
was reported to phosphorylate HuR at S242, promoting its
nuclear retention [40, 74]( Figure 1).
6. Concluding Remarks
HuR function is regulated by several kinases that play
central roles in the DNA damage response, notably those in
the ATM/ATR → Chk1/Chk2 pathway. Together with PKC
and p38, these signaling cascades govern HuR’s cytoplas-
mic abundance and interaction with target mRNAs. It is
intriguing that these kinases converge on a shared substrate
protein, HuR, which potently inﬂuences gene expression
patternsposttranscriptionally.Adeeperunderstandingofthe
signaling pathways that govern HuR function is helping to
elucidate HuR’s role in the overall DDR and in the gene
expression changes that ensue.
The emergence of HuR a key eﬀector of the DDR
program has important biological and clinical implications.
First, it suggests that modulation of gene expression by
ATM/ATR → Chk1/Chk2 is strongly inﬂuenced by HuR;
consequently, cells with impaired ATM/ATR → Chk1/Chk2
signaling could express diﬀerent subsets of proteins due
to aberrant HuR function (localization and RNA-binding
activity). Second, since lowering HuR levels or preventing
itsphosphorylationreducedcellsurvivalfollowinggenotoxic
damage [26, 27, 75], HuR could be a promising target
for therapeutic intervention. Third, the high levels of HuR
observed in many cancers (which appear to underlie HuR’s
role in tumorigenesis [76, 77]) could engender an eﬀective
DDR in cancer cells. Thus, cancer treatments that do not rely
on DNA damage might be advantageous when tumoral HuR
levels are elevated.
In sum, the posttranscriptional control of gene expres-
sion is particularly important during the DDR, when tran-
scription may be depressed to avoid the synthesis of aberrant
transcripts. Through post-translational modiﬁcation by the
kinases reviewed here (primarily ATM/ATR → Chk1/Chk2,
but also PKC and p38), HuR helps to orchestrate protein
expression from pre-existing mRNAs following damage to
DNA.Inthiscapacity,HuRisakeyfactorthathelpstoensure
the maintenance of cellular homeostasis following genotoxic
injury.6 Journal of Nucleic Acids
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